Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMY0V6J)

Drug Name
VG-106 Drug Info
Synonyms Anticancer cytokine, Viragen
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Terminated [1]
Cross-matching ID
TTD Drug ID
DMY0V6J

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Discontinued Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Cytokine receptor unspecific (CRF)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AD-452 DMMFLXN Rheumatoid arthritis FA20 Phase 2 [3]
IRX-2 DMODLN7 Acute myeloid leukaemia 2A60 Phase 2 [4]
JTE-607 DM1BQFY Sepsis 1G40-1G41 Discontinued in Phase 2 [5]
VP-025 DM0HZBU Alzheimer disease 8A20 Discontinued in Phase 1 [6]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cytokine receptor unspecific (CRF) TTXM6JN NOUNIPROTAC Modulator [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025763)
2 WO patent application no. 2011,0955,45, Peptides capable of binding to serum albumin and compounds, constructs and polypeptides comprising the same.
3 Detection of apoptosis by RT-PCR array in mefloquine-induced cochlear damage. Journal of Otology Volume 6, Issue 1, June 2011, Pages 1-9.
4 Clinical pipeline report, company report or official report of IRX Therapeutics.
5 JTE-607, a novel inflammatory cytokine synthesis inhibitor without immunosuppression, protects from endotoxin shock in mice. Inflamm Res. 1999 Aug;48(8):461-8.
6 List of Drugs in Development for Neurodegenerative Diseases. Neurodegenerative Dis 2007;4:443-486.